Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Acne Vulgaris
Conditions
Interventions
Tazarotene Foam
Vehicle Foam
Locations
18
United States
The Laser Institute for Dermatology
Santa Monica, California, United States
FXM Research Corporation
Miami, Florida, United States
Atlanta Dermatology & Vein Research Center, PC
Alpharetta, Georgia, United States
Gwinnett Clinical Research Center, Inc.
Snellville, Georgia, United States
Hudson Dermatology
Evansville, Indiana, United States
Dermatology Specialists
Louisville, Kentucky, United States
Start Date
October 1, 2009
Primary Completion Date
November 1, 2010
Completion Date
November 9, 2010
Last Updated
May 18, 2017
NCT07205107
NCT05891795
NCT06501560
NCT03883269
NCT07469228
NCT06415305
Lead Sponsor
Stiefel, a GSK Company
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions